Long‐pulsed 1,064‐nm gallium arsenide laser surgical device treatment for improving symptoms of onychomycosis: a comparative analysis
International Journal of Dermatology · 2023
DOI: 10.1111/ijd.16869 ↗Kurz gefasst
Kontrollierte klinische Studie in der Zeitschrift International Journal of Dermatology, 2023. Verfasst von Sun Young Choi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Gwangmyeong-si, Republic of Korea. Hauptthemen laut MEDLINE: Laser Therapy, Lasers, Solid-State, Onychomycosis. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
Background
Onychomycosis is the most common infective nail disease, and treatment includes topical and systemic antifungal medications. Recently, laser therapy has emerged as a therapeutic option for patients who are unable to take oral antifungal agents. We investigated the effectiveness and safety of a novel long‐pulsed 1,064‐nm gallium arsenide (GaAs) laser surgical device for onychomycosis.
Methods
This 24‐week single‐center, single‐blind, active‐controlled exploratory clinical study comparatively evaluated the long‐pulsed 1,064‐nm GaAs laser (Healer1064) with the short‐pulsed Nd:YAG laser surgical device in 20 participants randomly assigned to receive either test or control treatment at 4‐week intervals during the 12‐week treatment period. The rate of clinical improvement was evaluated by two independent dermatologist evaluators using the Onychomycosis Severity Index‐score (OSI‐score) and Turbidity Scale with standard photographs. Overall improvement and patient satisfaction were evaluated. Safety evaluation included pain intensity and adverse events.
Results
In 44 (test: 25; control: 19) cases in 19 participants who completed treatment, the clinical improvement rate in the test and control groups was 52.00% (13/52 cases) and 44.44% (9/19 cases), respectively, with significantly lower pain scores in the test than the control group for every treatment visit ( P < 0.05) and without severe adverse events.
Conclusions
The novel long‐pulsed 1,064‐nm GaAs laser showed greater, albeit nonsignificant, clinical improvement and was associated with less pain during treatment. Thus, the Healer1064 can provide satisfactory treatment outcomes through painless and effective improvement in onychomycosis symptoms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Gwangmyeong-si, Republic of Korea.
- Department of Dermatology, Chung-Ang University College of Medicine, Seoul, Republic of Korea.
- Department of Dermatology, National Police Hospital, Seoul, Republic of Korea.
ORCID-Profile: Sun Young Choi, Sun Hye Shin, Joon Seok, Kwang Ho Yoo, Beom Joon Kim
Zitieren
APA
Choi, S. Y., Shin, S. H., Seok, J., Ko, E. J., Yoo, K. H., & Kim, B. J. (2023). Long‐pulsed 1,064‐nm gallium arsenide laser surgical device treatment for improving symptoms of onychomycosis: a comparative analysis. International Journal of Dermatology. https://doi.org/10.1111/ijd.16869
Vancouver
Choi SY, Shin SH, Seok J, Ko EJ, Yoo KH, Kim BJ. Long‐pulsed 1,064‐nm gallium arsenide laser surgical device treatment for improving symptoms of onychomycosis: a comparative analysis. International Journal of Dermatology. 2023. doi:10.1111/ijd.16869
BibTeX
@article{Choi2023,
author = {Choi, Sun Young and Shin, Sun Hye and Seok, Joon and Ko, Eun Jung and Yoo, Kwang Ho and Kim, Beom Joon},
title = {Long‐pulsed 1,064‐nm gallium arsenide laser surgical device treatment for improving symptoms of onychomycosis: a comparative analysis},
journal = {International Journal of Dermatology},
year = {2023},
doi = {10.1111/ijd.16869}
}
EUVIMED